التفاصيل البيبلوغرافية
| العنوان: |
RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study |
| المؤلفون: |
Carlo-Stella, Carmelo, Mazza, Rita *, Manier, Salomon, Facon, Thierry *, Yoon, Sung-Soo, Koh, Youngil *, Harrison, Simon J, Er, Jeremy *, Pinto, Antonio *, Volzone, Francesco *, Perrone, Giulia *, Corradini, Paolo, Cazaubiel, Titouan *, Hulin, Cyrille *, Touzeau, Cyrille *, Moreau, Philippe *, Ocio, Enrique M., Montes Gaisan, Carmen Maria *, Popat, Rakesh *, Leong, Sarah *, Offner, Fritz, Rodriguez Otero, Paula *, Alfonso-Pierola, Ana *, Bröske, Ann-Marie E *, Dekhtiarenko, Iryna *, Helms, Hans-Joachim *, Belli, Sara *, Rossmann, Eva *, Fauti, Tanja *, Eckmann, Jan *, Moore, Tom *, Schneider, Meike *, Jacob, Wolfgang *, Weisser, Martin *, Hutchings, Martin *, Riley, Caroline Hasselbalch * |
| المصدر: |
In Blood 15 November 2022 140 Supplement 1:397-399 |
| قاعدة البيانات: |
ScienceDirect |
